b TTR was calculated just in 861 patients A complete of 162 patients (17.5%) suffered relevant problems (nonmajor): hemorrhagic (130 individuals, 14%) and thrombotic (46 individuals, 5%), or both (14
ROCK inhibitors
b TTR was calculated just in 861 patients A complete of 162 patients (17.5%) suffered relevant problems (nonmajor): hemorrhagic (130 individuals, 14%) and thrombotic (46 individuals, 5%), or both (14